Morphine drugs market to reach $30.17 billion by 2030 at 5.3% CAGR, driven by increasing prevalence of chronic pain conditions.
Read More
The global montelukast sodium market to reach $6.33 billion by 2030 at 8.4% CAGR, driven by increasing prevalence of asthma.
Read More
Monoclonal antibody therapeutics market to reach $396.1 billion by 2030 at 11.9% CAGR, driven by rising prevalence of autoimmune diseases.
Read More
Monoclonal antibodies market to reach $464.39 billion by 2030 at 12.6% CAGR, driven by increasing prevalence of cost-efficient biosimilar monoclonal antibodies.
Read More
Molecular targeted therapy market to reach $107.64 billion by 2030 at 8.4% CAGR, driven by rise of personalized medicine.
Read More
Modular fill-finish micro-factory market to reach $2.96 billion by 2030 at 11.1% CAGR, driven by increasing demand for personalized medicines.
Read More
Minimal residual disease testing market to reach $3.31 billion by 2030 at 13.1% CAGR, driven by increasing prevalence of cancer.
Read More
Mineral supplements market to reach $24.28 billion by 2030 at 6.3% CAGR, driven by increased sports and fitness activities.
Read More
Milk protein concentrate market to reach $4.25 billion by 2030 at 6.9% CAGR, driven by rising demand for high-protein foods.
Read More
The global migraine drugs market to reach $7.47 billion by 2030 at 5.5% CAGR, driven by increase in prevalence of migraine.
Read More